Quest Diagnostics Inc: executive vice president & CFO Sam Samad received 90 shares

What happened Sam Samad, executive vice president & CFO, received 90 shares as an award/acquisition at $235.94 per share, totaling $21,235, reported on Oct 23, 2026 for a transaction dated Oct 21, 2026.

Key details

• Transaction date and price: Oct 21, 2026 at $235.94 per share.
• Filing date: Oct 23, 2026.
• Shares received: 90 shares for $21,235.
• Shares owned after the transaction: not reported in the provided filing excerpt.
• Footnote: "Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4."

Why it may matter

• The shares were acquired through a dividend reinvestment plan rather than an open-market purchase.
• The filing was used to report the reinvestment early even though the transaction was eligible for deferred reporting on Form 5.
  This filing does not show why the insider traded or why the company acted.